Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

CASE REPORT

Interstitial lung disease associated with FOLFOX chemotherapy

Lim Joo Han, Kim Hoon, Choi Woong Gil, Lee Moon Hee

Year : 2010| Volume: 6| Issue : 4 | Page no: 546-548

   This article has been cited by
 
1 Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer
Shogbon, A.O. and Hap, J. and Dretler, R. and Dalvi, A.G.
Journal of Pharmacy Practice. 2013; 26(1): 62-66
[Pubmed]  [Google Scholar]
2 Oxaliplatin-induced lung toxicity. case report and review of the literature
Prochilo, T. and Abeni, C. and Bertocchi, P. and Zaniboni, A.
Current Drug Safety. 2012; 7(2): 179-182
[Pubmed]  [Google Scholar]
3 Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer
Hannan, L.M. and Yoong, J. and Chong, G. and McDonald, C.F.
Radiology and Oncology. 2012; 46(4): 360-362
[Pubmed]  [Google Scholar]
4 Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer
Liam M Hannan,Jaclyn Yoong,Geoffrey Chong,Christine F Mcdonald
Radiology and Oncology. 2012; 46(4)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article